BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 18307024)

  • 1. Complete response of a pancreatic adenosquamous carcinoma to chemoradiotherapy.
    Shibagaki K; Fujita K; Nakayama S; Takenaka M; Fukuba N; Matsui S; Ozaka M; Yoshinaga H; Masuzawa A; Watanabe A; Fujiwara H; Sugawara A; Fujita T; Mukai H; Kinoshita Y
    Int J Clin Oncol; 2008 Feb; 13(1):74-7. PubMed ID: 18307024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salvage pancreaticoduodenectomy after complete response to chemoradiotherapy for a previously unresectable pancreatic adenosquamous carcinoma: a case report.
    Elias A; Chatzizacharias NA; Xanthis A; Corrie P; Davies S; Brais RJ; Jamieson NV; Praseedom RK; Huguet E; Harper SJF; Jah A
    Medicine (Baltimore); 2015 Feb; 94(6):e499. PubMed ID: 25674740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [How toxic and effective is simultaneous radiochemotherapy with hydroxyurea, 5-FU and cisplatin in cervix carcinoma?].
    Lindner H
    Strahlenther Onkol; 1998 Nov; 174(11):601-2. PubMed ID: 9830445
    [No Abstract]   [Full Text] [Related]  

  • 4. [A case of successful treatment by low-dose 5-fluorouracil and cisplatin for liver metastases of esophageal adenosquamous carcinoma].
    Uchikado Y; Natsugoe S; Okumura H; Matsumoto M; Setoyama T; Takigawa J; Haraguchi Y; Ishigami S; Aikou T
    Gan To Kagaku Ryoho; 2006 Jan; 33(1):83-5. PubMed ID: 16410703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenosquamous carcinoma of the pancreas: successful treatment with extended radical surgery, intraoperative radiation therapy, and locoregional chemotherapy.
    Yamaue H; Tanimura H; Onishi H; Tani M; Kinoshita H; Kawai M; Yokoyama S; Uchiyama K
    Int J Pancreatol; 2001; 29(1):53-8. PubMed ID: 11558633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase I trial of escalating-dose irinotecan given weekly with cisplatin and concurrent radiotherapy in locally advanced esophageal cancer.
    Ilson DH; Bains M; Kelsen DP; O'Reilly E; Karpeh M; Coit D; Rusch V; Gonen M; Wilson K; Minsky BD
    J Clin Oncol; 2003 Aug; 21(15):2926-32. PubMed ID: 12885811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concomitant chemobrachyradiotherapy with ifosfamide and cisplatin followed by consolidation chemotherapy in the treatment of locally advanced adenocarcinoma or adenosquamous carcinoma of the cervix uteri.
    Vrdoljak E; Boraska Jelavic T; Saratlija-Novakovic Z; Hamm W
    Eur J Gynaecol Oncol; 2005; 26(6):602-4. PubMed ID: 16398217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concomitant intraarterial cisplatin, intravenous 5-flourouracil, and split-course radiation therapy for locally advanced unresectable pancreatic adenocarcinoma: a phase II study of the Puget Sound Oncology Consortium (PSOC-703).
    Thomas CR; Weiden PL; Traverso LW; Thompson T
    Am J Clin Oncol; 1997 Apr; 20(2):161-5. PubMed ID: 9124192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study.
    Whitney CW; Sause W; Bundy BN; Malfetano JH; Hannigan EV; Fowler WC; Clarke-Pearson DL; Liao SY
    J Clin Oncol; 1999 May; 17(5):1339-48. PubMed ID: 10334517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of unresectable, locally advanced pancreatic adenocarcinoma with combined radiochemotherapy with 5-fluorouracil, leucovorin and cisplatin.
    Kornek GV; Schratter-Sehn A; Marczell A; Depisch D; Karner J; Krauss G; Haider K; Kwasny W; Locker G; Scheithauer W
    Br J Cancer; 2000 Jan; 82(1):98-103. PubMed ID: 10638974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results of a phase II trial of epirubicin and cisplatin (EP) before and after irradiation and 5-fluorouracil in locally advanced pancreatic cancer: an EORTC GITCCG study.
    Wagener DJ; Hoogenraad WJ; Rougier P; Lusinchi A; Taal BG; Veenhof CH; de Graeff A; Conroy T; Curran D; Sahmoud T; Wils J
    Eur J Cancer; 1996 Jul; 32A(8):1310-3. PubMed ID: 8869091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response of adenosquamous carcinoma of the pancreas to interferon-alpha, tumor necrosis factor-alpha and 5-fluorouracil combined treatment.
    Tanaka N; Ohoida J; Matuno T; Gouchim A; Iwagaki H; Moreira LF; Orita K
    Anticancer Res; 1994; 14(6B):2739-42. PubMed ID: 7872711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term follow-up of RTOG 92-10: cervical cancer with positive para-aortic lymph nodes.
    Grigsby PW; Heydon K; Mutch DG; Kim RY; Eifel P
    Int J Radiat Oncol Biol Phys; 2001 Nov; 51(4):982-7. PubMed ID: 11704321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I/II trial of hyperfractionated accelerated chemoradiotherapy for unresectable advanced pancreatic cancer.
    Tsujie M; Nakamori S; Tanaka E; Nagano H; Umeshita K; Dono K; Sakon M; Inoue T; Inoue T; Monden M
    Jpn J Clin Oncol; 2006 Aug; 36(8):504-10. PubMed ID: 16855011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Twice-daily fractionation of external irradiation with brachytherapy and chemotherapy in carcinoma of the cervix with positive para-aortic lymph nodes: Phase II study of the Radiation Therapy Oncology Group 92-10.
    Grigsby PW; Lu JD; Mutch DG; Kim RY; Eifel PJ
    Int J Radiat Oncol Biol Phys; 1998 Jul; 41(4):817-22. PubMed ID: 9652843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Irinotecan, cisplatin, and radiation in esophageal cancer.
    Ilson DH; Minsky B; Kelsen D
    Oncology (Williston Park); 2002 May; 16(5 Suppl 5):11-5. PubMed ID: 12109799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemoradiotherapy in the treatment of regional pancreatic carcinoma: a phase II study.
    Al-Sukhun S; Zalupski MM; Ben-Josef E; Vaitkevicius VK; Philip PA; Soulen R; Weaver D; Adsay V; Heilbrun LK; Levin K; Forman JD; Shields AF
    Am J Clin Oncol; 2003 Dec; 26(6):543-9. PubMed ID: 14663369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of treatment tolerance and outcomes in patients with cervical cancer treated with concurrent chemoradiotherapy in a prospective randomized trial or with standard treatment.
    Torres MA; Jhingran A; Thames HD; Levenback CF; Bodurka DC; Ramondetta LM; Eifel PJ
    Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):118-25. PubMed ID: 17869451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case of gastric adenosquamous carcinoma successfully treated with second-line chemotherapy (CPT-11 and CDDP)].
    Ishiguro A; Takahata T; Hirose K; Matsumoto Y; Tanaka S; Suzuki K; Hanada N; Itoh J; Kawasaki H; Kijima H; Fukuda S; Saijo Y
    Gan To Kagaku Ryoho; 2010 Aug; 37(8):1579-82. PubMed ID: 20716891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxicities and effects of involved-field irradiation with concurrent cisplatin for unresectable carcinoma of the pancreas.
    Kawakami H; Uno T; Isobe K; Ueno N; Aruga T; Sudo K; Yamaguchi T; Saisho H; Kawata T; Ito H
    Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1357-62. PubMed ID: 16029793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.